MitchellRosner Univeristy of Virginia HealthUnited States

MitchellRosner
Mitchell H. Rosner, MD, FACPrChairman, Department of MedicinerAssociate Professor of MedicinerUniversity of Virginia Health SystemrCharlottesville, VirginiarrMitchell Rosner, MD, FACP is the Henry B. Mulholland Professor of Medicine in the Division of Nephrology and Chairman for the Department of Medicine at the University of Virginia. He received his medical degree from the Medical College of Georgia, and completed his residency and a fellowship at the University of Virginia. He is board certified in internal medicine and nephrology.rrDr. Rosner has a strong interest in education and serves on a number of national committees devoted to educational aspects of medical training. Dr. Rosner is the recipient of numerous honors including the University of Virginia All-University Teaching Award and the University Master Educator Award. rrHis clinical practice focus is the medical care of patients with all forms of kidney disease—from acute kidney failure to end-stage kidney disease. His special interest in patients with polycystic kidney disease led Dr. Rosner to found the first regional clinic to specifically address the clinical management of patients with polycystic kidney disease. Dr. Rosner serves as the medical director for this multidisciplinary, patient-centered clinic that also provides selected patients the opportunity to enroll in clinical trials investigating novel therapies for this disease. rrHis research interests include the pathogenesis and management of disorders of sodium and water balance, the treatment of polycystic kidney disease, and the development of novel therapeutics for acute kidney injury. Most recently, he chaired the international consensus group on exercise-associated hyponatremia.rrDr. Rosner has published over 100 articles in peer-reviewed medical journals, and serves on the editorial boards of numerous journals including the American Journal of Kidney Disease and the Clinical Journal of the American Society of Nephrology
Institution

Day 1 - Sunday April 14, 2024

Time Session
3 p.m.
4 p.m.
Angela Yee-MoonWang Chairperson Hong Kong/SingaporeSingapore
ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil
  • Is Magnesium a Missing Puzzle for Vascular Calcification in CKD?
    SolaAoun Bahous Speaker sola.bahous@gmail.comLebanese American University School of MedicineLebanon
  • Should Potassium Be Restricted or Not in CKD?
    RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Metabolic Acidosis in CKD: When to Treat? What to Target?
    MitchellRosner Speaker Univeristy of Virginia HealthUnited States
  • Q and A
Hall A

Day 2 - Monday April 15, 2024

Time Session
3 p.m.
4 p.m.
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
  • Overview of Hyponatremia
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Pro: Current Guidelines are Appropriate
    HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States
  • Con: Current Guidelines are Too Conservative
    CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States
  • Discussion
Hall C3

Pre-Congress - Saturday April 13, 2024

Time Session
9 a.m.
11 a.m.
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Changing Paradigms in the Care of Acute Kidney Injury
    MarliesOstermann Speaker King's College LondonUnited Kingdom
  • Update on Electrolyte Disorders
    MitchellRosner Speaker Univeristy of Virginia HealthUnited States
  • How to Incorporate Genetic Testing in Nephrology
    MoumitaBarua Speaker moumita.barua@uhn.caCanada
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4
11:30 a.m.
1:30 p.m.
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Changing Paradigms in the Care of Chronic Kidney Disease: Slowing Progression
    Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
  • What
    ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil
  • Therapeutic Approaches for Polycystic Kidney Disease
    Roman-UlrichMueller Speaker roman-ulrich.mueller@uk-koeln.deUniversity of CologneGermany
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4
2:15 p.m.
4:15 p.m.
MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina
MitchellRosner Chairperson Univeristy of Virginia HealthUnited States
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Glomerular Diseases: Update
    YelenaDrexler Speaker yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • Transplantation 2023 and Beyond
    ShrutiTapiawala Speaker shruti16374@gmail.comGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, MumbaiIndia
  • Hypertension and the Kidney
    GeorgeThomas Speaker thomasg3@ccf.orgASNUnited States
  • Glomerular Diseases: Case Presentation
    MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina
  • Q and A
Hall C4